Moawia Mohammed Ali Elhassan, Associate Professor at University of Gezira, Consultant of Clinical and Radiation Oncology at Universal Hospital Sudan, shared a post on LinkedIn:
“How effective is reirradiation for spinal metastases?
A recent single-institution retrospective study, recently published at Practical Radiation Oncology Journal (PRO), offers compelling evidence for the use of SBRT in this challenging clinical scenario.
The study analyzed outcomes for patients receiving either single-fraction (18-24 Gy) or three-fraction (30-36 Gy) SBRT.
Key Findings:
- Local control was excellent, with only a 12% incidence of failure at the one-year.
- OS at the one-year was 61%.
- The treatment was well-tolerated. Notably, zero cases of radiation myelitis were reported in lesions at L1 or above (n=79).
- Chronic peripheral neuropathy was observed in only 5 patients.
This large-scale institutional experience demonstrates that reSBRT provides excellent local control with a low risk of severe toxicity, making it a viable and effective salvage option for Spine Metastases.”
Title: Long-Term Outcomes After Reirradiation With Spine Stereotactic Body Radiation Therapy: Single-Institutional Retrospective Experience
Authors: J. John Lucido, Trey C. Mullikin, W. Scott Harmsen, Sydney D. Pulsipher, Benjamin A. Johnson-Tesch, Jonathan M. Morris, Peter S. Rose, Brittany L. Siontis, Debra H. Brinkmann, Dawn Owen, Sean S. Park, Anne W. Rajkumar, Roman O. Kowalchuk, Kenneth W. Merrell
Read The Full Article
Other articles about Radiation Oncology on OncoDaily.